American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$223M |
| 2 |
Fortive
FTV
|
+$192M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$175M |
| 4 |
American Water Works
AWK
|
+$137M |
| 5 |
Medtronic
MDT
|
+$124M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MXIM
Maxim Integrated Products
MXIM
|
+$400M |
| 2 |
Becton Dickinson
BDX
|
+$295M |
| 3 |
Cummins
CMI
|
+$259M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$253M |
| 5 |
Kimberly-Clark
KMB
|
+$252M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.68% |
| 2 | Healthcare | 15.63% |
| 3 | Consumer Discretionary | 13.97% |
| 4 | Financials | 13.63% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Target
TGT
$70.4B
| $80.8M | 0.07% |
513,284
-451,683
| -47% | -$62M |
|
|
NBIS
277
Nebius Group N.V.
NBIS
$73.3B
| $79.9M | 0.07% |
1,225,107
-11,911
| -1% | -$710K |
|
|
ENV
278
DELISTED
ENVESTNET, INC.
ENV
| $79.7M | 0.07% |
1,032,741
+33,866
| +3% | +$2.7M |
|
279
Peloton Interactive
PTON
$2.39B
| $79.3M | 0.07% |
799,533
-120,983
| -13% | -$8.9M |
|
280
Graco
GGG
$13.3B
| $78.4M | 0.07% |
1,277,369
-110,924
| -8% | -$6.2M |
|
|
ABMD
281
DELISTED
Abiomed Inc
ABMD
| $77.2M | 0.07% |
278,627
+45,119
| +19% | +$13M |
|
282
IBM
IBM
$224B
| $77M | 0.07% |
661,641
-140,238
| -17% | -$16.5M |
|
|
IMMU
283
DELISTED
Immunomedics Inc
IMMU
| $76.6M | 0.07% |
900,980
-1,863,220
| -67% | -$94.2M |
|
284
Avantis Emerging Markets Equity ETF
AVEM
$27B
| $76.5M | 0.07% |
1,478,531
-25,946
| -2% | -$1.34M |
|
285
Compass Diversified
CODI
$919M
| $76.2M | 0.07% |
3,998,648
+45,238
| +1% | +$769K |
|
286
Chewy
CHWY
$9.04B
| $75.4M | 0.07% |
1,375,307
+778,906
| +131% | +$42M |
|
287
Tandem Diabetes Care
TNDM
$1.6B
| $75.2M | 0.07% |
662,216
-31,284
| -5% | -$3.29M |
|
288
Globant
GLOB
$1.67B
| $74.3M | 0.07% |
414,495
-13,929
| -3% | -$2.4M |
|
289
Las Vegas Sands
LVS
$29.5B
| $72.8M | 0.06% |
1,561,283
-1,241,025
| -44% | -$59.3M |
|
290
Repligen
RGEN
$9.22B
| $72.5M | 0.06% |
491,698
+469,434
| +2,108% | +$67.1M |
|
291
Baker Hughes
BKR
$62.9B
| $71.9M | 0.06% |
5,406,693
+255,260
| +5% | +$3.9M |
|
292
Spectrum Brands
SPB
$2.06B
| $71.7M | 0.06% |
1,253,524
-171,878
| -12% | -$9.42M |
|
293
Expedia Group
EXPE
$38.6B
| $70.9M | 0.06% |
772,829
-417,370
| -35% | -$37.5M |
|
294
SelectQuote
SLQT
$127M
| $70.5M | 0.06% |
3,482,326
+1,022,773
| +42% | +$21.3M |
|
295
Ameren
AEE
$30.3B
| $70.3M | 0.06% |
889,105
+18,916
| +2% | +$1.48M |
|
296
Fastly Inc
FSLY
$4.56B
| $68.9M | 0.06% |
735,546
-712,058
| -49% | -$61.8M |
|
297
Ryanair
RYAAY
$30.9B
| $68.4M | 0.06% |
2,091,900
+499,670
| +31% | +$15.5M |
|
|
BPMC
298
DELISTED
Blueprint Medicines
BPMC
| $68.2M | 0.06% |
736,039
+33,460
| +5% | +$2.58M |
|
299
Nordson
NDSN
$17.2B
| $66.8M | 0.06% |
348,332
+81
| +0% | +$15.6K |
|
300
CDW
CDW
$17.1B
| $66.3M | 0.06% |
554,296
-331,644
| -37% | -$37.9M |
|
Similar funds
American Century Companies's Q3 2020 Portfolio in Review
As of Q3 2020, American Century Companies held 1,900 positions worth $113B, up 6.9% from $105B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
American Century Companies's Q3 2020 filing shows 187 new, 982 increased, 613 reduced and 100 closed positions. Its largest new stake was Fortive: 4,206,223 shares worth $202M. The largest sale was Maxim Integrated Products, an estimated $400M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- American Century Companies's largest Q3 2020 buy was Fortive: 4,206,223 shares worth $202M.
- American Century Companies added most to PepsiCo in Q3 2020, an estimated $223M increase.
- American Century Companies's biggest Q3 2020 reduction was Maxim Integrated Products, cutting an estimated $400M.
- American Century Companies fully exited Service Corp International in Q3 2020, selling an estimated $89.5M.
- American Century Companies's ten largest holdings make up 23% of its $113B portfolio in Q3 2020.
- American Century Companies opened 187 new positions and closed 100 in Q3 2020.
- American Century Companies's portfolio value rose 6.9% quarter-over-quarter to $113B.
Based on American Century Companies's 13F filing for Q3 2020, filed 13 Nov 2020.